Medherant

Medherant is a clinical-stage company developing innovative therapies using its novel transdermal drug delivery technology, the TEPI patch. The company’s lead program is a testosterone patch for women. There is significant interest in transdermal drug delivery to overcome some of the drawbacks of oral administration, such as peaks in drug levels that may cause side effects and poor compliance. Patches are also a more convenient method of delivering drugs through the skin compared to gels and creams, offering better dose control.